• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dopaminergic treatment of restless legs and rebound phenomenon.

作者信息

Guilleminault C, Cetel M, Philip P

机构信息

Stanford University Sleep Disorders Center, CA 94304.

出版信息

Neurology. 1993 Feb;43(2):445. doi: 10.1212/wnl.43.2.445.

DOI:10.1212/wnl.43.2.445
PMID:8094897
Abstract
摘要

相似文献

1
Dopaminergic treatment of restless legs and rebound phenomenon.
Neurology. 1993 Feb;43(2):445. doi: 10.1212/wnl.43.2.445.
2
Restless legs syndrome.不宁腿综合征
JAMA. 1995 Oct 18;274(15):1191-2.
3
My doctor prescribed Sinemet for my restless legs and it was a catastrophe. Why did you recommend it in a recent article?
Johns Hopkins Med Lett Health After 50. 1998 Feb;10(12):8.
4
Augmentation of the restless legs syndrome with carbidopa/levodopa.
Sleep. 1996 Apr;19(3):205-13. doi: 10.1093/sleep/19.3.205.
5
A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.一项使用卡比多巴/左旋多巴和丙氧芬治疗睡眠期周期性肢体运动的双盲、安慰剂对照研究。
Sleep. 1993 Dec;16(8):717-23. doi: 10.1093/sleep/16.8.717.
6
Dopaminergic augmentation of restless legs syndrome.多巴胺能药物治疗不宁腿综合征。
Sleep Med Rev. 2010 Oct;14(5):339-46. doi: 10.1016/j.smrv.2009.11.006. Epub 2010 Mar 12.
7
L-dopa in uremic patients with the restless legs syndrome.左旋多巴用于患有不宁腿综合征的尿毒症患者。
Int J Neurosci. 1987 Aug;35(3-4):233-5. doi: 10.3109/00207458708987132.
8
Transient restless legs-like syndrome as a complication of opiate withrawal.短暂性不宁腿样综合征作为阿片类药物戒断的一种并发症。
Pharmacopsychiatry. 2003 Mar-Apr;36(2):70-2. doi: 10.1055/s-2003-39047.
9
[Restless legs, restless nights: therapeutic options in RLS].[不宁腿，不眠夜：不宁腿综合征的治疗选择]
MMW Fortschr Med. 2009 Mar 26;151(13):65-7, 69.
10
Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medications.
CANNT J. 2010 Apr-Jun;20(2):29-33; quiz 34-5.

引用本文的文献

1
Pharmacological Strategies for the Treatment of Restless Legs Syndrome.治疗不宁腿综合征的药理学策略
Curr Neurol Neurosci Rep. 2025 Aug 19;25(1):60. doi: 10.1007/s11910-025-01445-3.
2
Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline.不宁腿综合征和周期性肢体运动障碍的治疗：美国睡眠医学学会临床实践指南
J Clin Sleep Med. 2025 Jan 1;21(1):137-152. doi: 10.5664/jcsm.11390.
3
Pharmacological responsiveness of periodic limb movements in patients with restless legs syndrome: a systematic review and meta-analysis.
周期性肢体运动障碍患者的不安腿综合征的药物反应：系统评价和荟萃分析。
J Clin Sleep Med. 2023 Apr 1;19(4):811-822. doi: 10.5664/jcsm.10440.
4
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的药物和非药物治疗。
Curr Neuropharmacol. 2021;19(12):2233-2249. doi: 10.2174/1570159X19666210517115706.
5
Pharmacologic Treatment of Restless Legs Syndrome.不宁腿综合征的药物治疗。
Curr Neuropharmacol. 2021;19(3):372-382. doi: 10.2174/1570159X19666201230150127.
6
Restless legs syndrome.不宁腿综合征
Clin Med (Lond). 2016 Aug;16(4):379-82. doi: 10.7861/clinmedicine.16-4-379.
7
A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease).不宁腿综合征（威利-埃克博姆病）当前治疗策略综述。
Clin Med (Lond). 2014 Oct;14(5):520-4. doi: 10.7861/clinmedicine.14-5-520.
8
Review of the treatment of restless legs syndrome: focus on gabapentin enacarbil.不安腿综合征的治疗综述：聚焦于加巴喷丁依卡倍特
J Cent Nerv Syst Dis. 2012 Sep 17;4:147-56. doi: 10.4137/JCNSD.S9107. Print 2012.
9
Diagnosis and treatment of sleep disorders: a brief review for clinicians.睡眠障碍的诊断与治疗：临床医生简要综述
Dialogues Clin Neurosci. 2003 Dec;5(4):371-88. doi: 10.31887/DCNS.2003.5.4/vabad.
10
Restless legs syndrome: pathophysiology, clinical presentation and management.不宁腿综合征：病理生理学、临床表现和治疗。
Nat Rev Neurol. 2010 Jun;6(6):337-46. doi: 10.1038/nrneurol.2010.55.